StockData
AXIM Biotechnologies, Inc. logo

AXIM Biotechnologies, Inc. (AXIM) stock

AXIMOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2024, quarter ended Jun 30, 2024Last filing: 10-Q on Aug 19, 2024
$0.00+0.00 (+2.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

AXIM Biotechnologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

AXIM Biotechnologies's operating income for the twelve months ending Jun 30, 2024 was -$2.31M. For fiscal 2023 it was -$2.75M. The highest annual figure on record is -$505.73K in fiscal 2014.

Annual operating income

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$2.75M–
FY2022Dec 31, 2022-$4.65M–
FY2021Dec 31, 2021-$13.97M–
FY2020Dec 31, 2020-$4.95M–
FY2019Dec 31, 2019-$3.11M–
FY2018Dec 31, 2018-$5.04M–
FY2017Dec 31, 2017-$3.15M–
FY2016Dec 31, 2016-$3.76M–
FY2015Dec 31, 2015-$10.05M–
FY2014Dec 31, 2014-$505.73K–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2024Jun 30, 2024-$569.44K–
Q1 FY2024Mar 31, 2024-$401.56K–
Q4 FY2023Dec 31, 2023-$753.94K–
Q3 FY2023Sep 30, 2023-$588.54K–
Q2 FY2023Jun 30, 2023-$697.73K–
Q1 FY2023Mar 31, 2023-$710.63K–
Q4 FY2022Dec 31, 2022-$1.14M–
Q3 FY2022Sep 30, 2022-$1.32M–
Q2 FY2022Jun 30, 2022-$1.06M–
Q1 FY2022Mar 31, 2022-$1.13M–
Q4 FY2021Dec 31, 2021-$7.65M–
Q3 FY2021Sep 30, 2021-$3.28M–
Q2 FY2021Jun 30, 2021-$2.18M–
Q1 FY2021Mar 31, 2021-$868.00K–
Q4 FY2020Dec 31, 2020-$2.26M–
Q3 FY2020Sep 30, 2020-$1.30M–
Q2 FY2020Jun 30, 2020-$662.86K–
Q1 FY2020Mar 31, 2020-$688.73K–
Q4 FY2019Dec 31, 2019-$568.49K–
Q3 FY2019Sep 30, 2019-$483.67K–
Q2 FY2019Jun 30, 2019-$583.44K–
Q1 FY2019Mar 31, 2019-$2.29M–
Q4 FY2018Dec 31, 2018-$723.12K–
Q3 FY2018Sep 30, 2018-$935.83K–
Q2 FY2018Jun 30, 2018-$1.34M–
Q1 FY2018Mar 31, 2018-$2.04M–
Q4 FY2017Dec 31, 2017-$1.05M–
Q3 FY2017Sep 30, 2017-$1.19M–
Q2 FY2017Jun 30, 2017-$437.25K–
Q1 FY2017Mar 31, 2017-$476.33K–
Q4 FY2016Dec 31, 2016-$770.22K–
Q3 FY2016Sep 30, 2016-$1.56M–
Q2 FY2016Jun 30, 2016-$491.49K–
Q1 FY2016Mar 31, 2016-$942.18K–
Q4 FY2015Dec 31, 2015-$6.31M–
Q3 FY2015Sep 30, 2015-$1.69M–
Q2 FY2015Jun 30, 2015-$1.56M–
Q1 FY2015Mar 31, 2015-$488.82K–
Q4 FY2014Dec 31, 2014-$370.10K–
Q3 FY2014Sep 30, 2014-$127.94K–

More AXIM Biotechnologies figures

See a number that looks wrong?